Commission Implementing Decision (EU) 2021/2148 of 3 December 2021 on the unresolved objections regarding terms and conditions of the authorisation of the biocidal product family Oxybio in accordance with Article 36 of Regulation (EU) No 528/2012 of the European Parliament and of the Council (notified under document C(2021) 8690)

Subscribe now to view and receive funding opportunities instantlly.

Want another formats or payment options? Call now: +34 91 119 69 77